These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28060226)

  • 21. The influence of integrated tuberculosis and human immunodeficiency virus service delivery on patient outcomes.
    Uyei J; Coetzee D; Macinko J; Weinberg SL; Guttmacher S
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):315-21. PubMed ID: 24670569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.
    Bassett IV; Coleman SM; Giddy J; Bogart LM; Chaisson CE; Ross D; Jacobsen MM; Robine M; Govender T; Freedberg KA; Katz JN; Walensky RP; Losina E
    J Acquir Immune Defic Syndr; 2016 Oct; 73(2):154-60. PubMed ID: 27632145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off.
    Jespersen S; Hønge BL; Esbjörnsson J; Medina C; da Silva Té D; Correira FG; Laursen AL; Østergaard L; Andersen A; Aaby P; Erikstrup C; Wejse C;
    Trop Med Int Health; 2016 Feb; 21(2):253-62. PubMed ID: 26616349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    Chaisson LH; Semitala FC; Asege L; Mwebe S; Katende J; Nakaye M; Andama AO; Marquez C; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
    AIDS; 2019 Apr; 33(5):895-902. PubMed ID: 30649057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.
    Losina E; Bassett IV; Giddy J; Chetty S; Regan S; Walensky RP; Ross D; Scott CA; Uhler LM; Katz JN; Holst H; Freedberg KA
    PLoS One; 2010 Mar; 5(3):e9538. PubMed ID: 20209059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa.
    Bassett IV; Huang M; Cloete C; Candy S; Giddy J; Frank SC; Freedberg KA; Losina E; Walensky RP; Parker RA
    J Int AIDS Soc; 2019 Jun; 22(6):e25326. PubMed ID: 31243898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial.
    Bassett IV; Giddy J; Chaisson CE; Ross D; Bogart LM; Coleman SM; Govender T; Robine M; Erlwanger A; Freedberg KA; Katz JN; Walensky RP; Losina E
    BMC Infect Dis; 2013 Aug; 13():390. PubMed ID: 23972276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized Trial.
    Hoffmann CJ; Mabuto T; Ginindza S; Fielding KL; Kubeka G; Dowdy DW; Churchyard GJ; Charalambous S
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):540-547. PubMed ID: 28471840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa.
    Naik R; Doherty T; Jackson D; Tabana H; Swanevelder S; Thea DM; Feeley FG; Fox MP
    J Int AIDS Soc; 2015; 18(1):19843. PubMed ID: 26058983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
    Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Outcomes of Children With HIV Infection and Drug-resistant TB in Three Provinces in South Africa, 2005-2008.
    Hall EW; Morris SB; Moore BK; Erasmus L; Odendaal R; Menzies H; van der Walt M; Smith SE
    Pediatr Infect Dis J; 2017 Dec; 36(12):e322-e327. PubMed ID: 28746263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.